Sahyadri Specialty Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Acute lymphoblastic leukaemia1 trial
• Acute myeloid leukaemia1 trial
• Chronic lymphocytic leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Lung cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 34 trials
• Phase 1/21 trial

Status

• Active, not recruiting3 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Abivax S.A.2 trials
• Geron Corporation1 trial
• Pfizer1 trial
• Sun Pharma Advanced Research Company Limited1 trial

Running trials

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

  NCT04576156· Phase 3· Geron Corporation· Source

• Active, not recruiting

  A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

  NCT03052608· Phase 3· Pfizer· Source

Closed trials

• Completed

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· Phase 3· Abivax S.A.· Source

• Terminated

  Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

  NCT02629692· Phase 1/2· Sun Pharma Advanced Research Company Limited· Source